[ET Net News Agency, 23 May 2022] Peijia Medical Limited (09996) said the group
received the approval from the National Medical Products Administration of the PRC (the
NMPA) for the registration application of Tethys AS Aspiration Catheter, making it the
group's twelfth NMPA approved neurointerventional product.
Tethys AS Aspiration Catheter is an acute ischemic stroke (AIS) revascularization
product developed by Achieva Medical (Achieva), a wholly-owned subsidiary of the company.
The product provides an effective solution for thrombus removal, featuring a wide lumen
and easy positioning.
The group also received the approval from NMPA for the registration application of
Fastunnel Delivery Balloon Dilation Catheter, making it the group's thirteenth NMPA
approved neurointerventional product.
Fastunnel Delivery Balloon Dilation Catheter is an innovative product developed by
Achieva. It is designed for treating intracranial atherosclerotic disease (ICAD). As the
first medical device in China which can realize balloon dilation and stent delivery at the
same time, its unique "zero exchange" technology will usher a new era of ICAD treatment.
(RC)